New drug hopes to regrow hair in severe alopecia
NCT ID NCT07205159
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a drug called FB102 in 32 adults with severe to very severe alopecia areata, a condition causing significant hair loss. Half receive the drug and half a placebo, all by IV. The main goal is to check safety, but researchers will also measure hair regrowth at 16 weeks using a standard scalp hair loss score.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FB102 (given intravenously)
What this could lead to
If it works, this could point toward a new treatment option for people with severe hair loss from alopecia areata.
What could go wrong
This is a very early Phase 1 trial with only 32 people, so it is primarily checking safety. It may not show clear hair regrowth, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Auckland
NOT_YET_RECRUITINGAuckland, Auckland, 0632, New Zealand
-
Christchurch
NOT_YET_RECRUITINGChristchurch, Canterbury, 8013, New Zealand
-
Coorparoo
RECRUITINGCoorparoo, Queensland, 4151, Australia
-
Palmerston North
NOT_YET_RECRUITINGPalmerston North, Palmerston North Central, 4414, New Zealand
-
South Yarra
NOT_YET_RECRUITINGSouth Yarra, Victoria, 3141, Australia
-
St Leonards
NOT_YET_RECRUITINGSaint Leonards, New South Wales (nsw), 2065, Australia